Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
2392 results about "Circulatory system" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
The circulatory system, also called the cardiovascular system or the vascular system, is an organ system that permits blood to circulate and transport nutrients (such as amino acids and electrolytes), oxygen, carbon dioxide, hormones, and blood cells to and from the cells in the body to provide nourishment and help in fighting diseases, stabilize temperature and pH, and maintain homeostasis.
Analyte sensor
Owner:DEXCOM INC
Analyte sensor
ActiveUS20090018424A1Sufficient flow rateReduce the amount requiredLocal control/monitoringDrug and medicationsAnalyteVascular Access Devices
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
ActiveUS20090242425A1Sufficient flow rateReduce the amount requiredImmobilised enzymesBioreactor/fermenter combinationsAnalyteVascular Access Devices
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Blood flow controlling apparatus
InactiveUS20060241745A1Avoid improper sealingPrevent leakageSuture equipmentsAnnuloplasty ringsNative tissuePlasma viscosity
A blood flow controlling apparatus, which is configured to be implanted into a blood circulatory system of a patient, comprises an anchoring means, which is arranged to fix the position of the apparatus in the blood circulatory system, and a valve means being connected to the anchoring means. The valve means is configured to be arranged within the blood circulatory system and is configured to be extendable in a direction transverse to blood flow in order to make contact with native tissue when inserted in the blood circulatory system. The valve means is further configured to release said contact as a result of being exposed to blood flow in a permitted direction.
Owner:EDWARDS LIFESCIENCES AG
Analyte sensor
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
InactiveUS20080197024A1Sufficient flow rateReduce the amount requiredImmobilised enzymesDrug and medicationsVascular Access DevicesAnalyte
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
ActiveUS20090182217A1Drug and medicationsMaterial analysis by electric/magnetic meansVascular Access DevicesAnalyte
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
ActiveUS20080200791A1Sufficient flow rateReduce the amount requiredLocal control/monitoringMicrobiological testing/measurementVascular Access DevicesAnalyte
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
ActiveUS20080200789A1Sufficient flow rateReduce the amount requiredLocal control/monitoringMicrobiological testing/measurementVascular Access DevicesAnalyte
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
InactiveUS20080200788A1Reduce the amount requiredIncrease volumeDrug and medicationsMedical devicesAnalyteVascular Access Devices
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
ActiveUS20090178459A1Drug and medicationsMaterial analysis by electric/magnetic meansAnalyteVascular Access Devices
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
ActiveUS20090131776A1Local control/monitoringMicrobiological testing/measurementVascular Access DevicesAnalyte
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Analyte sensor
ActiveUS20090131768A1Local control/monitoringMicrobiological testing/measurementVascular Access DevicesAnalyte
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Owner:DEXCOM
Guidable intravascular blood pump and related methods
InactiveUS7022100B1Integration of featureEliminate needGuide wiresControl devicesBlood pumpBlood vessel
An improved intravascular blood pump system (10) and related methods involving the broad inventive concept of equipping the intravascular blood pump (12) with guiding features such that the intravascular blood pump can be selectively positioned at a predetermined location within the circulatory system of a patient.
Owner:MAQUET CARDIOVASCULAR LLC
Sigmoid valve and method for its percutaneous implantation
A multi-leaflet valve adapted to serve as a prosthesis for diseased native valve of a mammal is incorporated in self-expandable or inflatable endovascular stents or stents to form a combination which is introduced on a catheter with a guide wire into the circulatory system of the mammal to replace the diseased native valve. Once the combination is at the desired location the stent is caused to expand and affix itself to the patient's vessel wall. The prosthetic valve has the shape of a truncated cone that has an inflow and an outflow orifice with leaflets forming the outflow orifice and forming a plurality of commissures. A first flexible circular support is affixed in a substantially circular fashion around the truncated cone in proximity of the inflow orifice, and a second flexible circular support is affixed at the location of the commissures to form a circle around the truncated cone in proximity of the outflow orifice. The circular supports maintain the shape of the valve during the surgical implantation procedure and thereafter.
Owner:THE INT HEART INST OF MONTANA FOUND
Methods and apparatus for perfusion of isolated tissue structure
Organs and other tissue structures are isolated and perfused with a therapeutic agent. Isolation is effected by endovascularly positioning catheters having occlusion balloons within the arteries or other blood vessels which supply blood to the organ. Similarly, blood flow from the organ back to the patient's circulatory system is blocked by endovascularly positioning one or more catheters carrying occlusion members within the veins or other blood vessels leading from the organ. The therapeutic agent may then be perfused through the organ in either an antegrade or retrograde fashion using the endovascularly positioned catheters while maintaining isolation.
Owner:PINPOINT THERAPEUTICS
Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
Owner:DEPUY SYNTHES PROD INC
Programmable thermostat incorporating air quality protection
InactiveUS6988671B2Mechanical apparatusSpace heating and ventilation safety systemsAir filtrationTemperature control
The invention is directed to programmable temperature control in which a controller may be programmed to control a thermal output of said temperature-modifying device, and to operate an air circulating system independently of the temperature-modifying device. The apparatus may incorporate a user input for entering air handling information to program the air circulating system to operate at predetermined intervals. The controller may be further programmed to receive air filtration information from the user input and to generate air filtration output information. The system may also be programmed to receive information regarding a characteristic of the air circulating system from an sensor for use in calculating the air filtration output information.
Owner:JOHNSON CONTROLS TECH CO INC
Stabilized single domain antibodies
InactiveUS20070178082A1Extended half-lifeAntibacterial agentsAntipyreticSingle-domain antibodySerum protein
The present invention relates to heterospecific polypeptide constructs comprising at least one single domain antibody directed against a therapeutic and / or diagnostic target and at least one single domain antibody directed against a serum protein, said construct having a prolonged lifetime in biological circulatory systems. The invention further relates to methods for stabilising VHHs in biological circulatory systems.
Owner:ABLYNX NV
Apparatus and methods for increasing the rate of solute concentration evolution in a supercritical process chamber
InactiveUS20080264443A1Avoid re-introductionSemiconductor/solid-state device manufacturingCleaning using liquidsChemical physicsMomentum
The present invention pertains to a system for processing semiconductor wafers. The processing may involve the removal of material from the wafers or deposition of material on the wafers. Various aspects of the invention include specialized pressurization, process vessel, recirculation, chemical addition, depressurization, and recapture-recycle subsystems. A solvent delivery mechanism can convert a liquid-state sub-critical solution to a supercritical processing solution and introduce it into a process vessel that contains a batch of wafers. The wafers may be rotated within the supercritical processing solution. The supercritical processing solution is preferably recirculated through the process vessel by a recirculation system. When chemical additives are added to a supercritical solvent, the momentum of the chemical additives are preferably matched to the momentum of the supercritical solvent. Additives may be added at a higher initial flow rate, then ramped down a lower flow rate, e.g., a steady-state flow rate.
Owner:NOVELLUS SYSTEMS
Medical imaging systems
A medical imaging system provides simultaneous rendering of visible light and fluorescent images. The system may employ dyes in a small-molecule form that remains in a subject's blood stream for several minutes, allowing real-time imaging of the subject's circulatory system superimposed upon a conventional, visible light image of the subject. The system may also employ dyes or other fluorescent substances associated with antibodies, antibody fragments, or ligands that accumulate within a region of diagnostic significance. In one embodiment, the system provides an excitation light source to excite the fluorescent substance and a visible light source for general illumination within the same optical guide that is used to capture images. In another embodiment, the system is configured for use in open surgical procedures by providing an operating area that is closed to ambient light. More broadly, the systems described herein may be used in imaging applications where a visible light image may be usefully supplemented by an image formed from fluorescent emissions from a fluorescent substance that marks areas of functional interest.
Owner:BETH ISRAEL DEACONESS MEDICAL CENT INC
Sigmoid valve and method for its percutaneous implantation
Owner:THE INT HEART INST OF MONTANA FOUND
Analyte sensor
ActiveUS8275438B2Local control/monitoringMicrobiological testing/measurementVascular Access DevicesAnalyte
Owner:DEXCOM INC
Safety catheter system and method
A catheter integral with a valved needle-free connector provides a safety catheter device configured to receive a blunt cannula and sharp needle forming an insertion mechanism. The sharp needle is mounted within a needle tube and a control handle is used to slide the sharp needle out of and into the protective needle tube. When the insertion mechanism is mounted to the connector and the control handle is used to slide the sharp needle out of the tube, a blunt cannula first moves into contact with and enters the bore of the valve mechanism of the connector opening it and protecting it from damage that may be caused by the sharp needle. The sharp needle is then extended through the connector and extends out the distal end of the catheter so that a venipuncture procedure may be performed to properly locate the catheter in the patient's circulatory system. Once located, the needle may be retracted into the insertion mechanism, the insertion mechanism disconnected from the connector, and discarded.
Owner:CAREFUSION 303 INC
Multi-channel medical imaging systems
A medical imaging system provides simultaneous rendering of visible light and fluorescent images. The system may employ dyes in a small-molecule form that remain in a subject's blood stream for several minutes, allowing real-time imaging of the subject's circulatory system superimposed upon a conventional, visible light image of the subject. The system may provide an excitation light source to excite the fluorescent substance and a visible light source for general illumination within the same optical guide used to capture images. The system may be configured for use in open surgical procedures by providing an operating area that is closed to ambient light. The systems described herein provide two or more diagnostic imaging channels for capture of multiple, concurrent diagnostic images and may be used where a visible light image may be usefully supplemented by two or more images that are independently marked for functional interest.
Owner:BETH ISRAEL DEACONESS MEDICAL CENT INC
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com